MSF at IAC 2012
The new understanding that antiretroviral therapy (ART) can significantly reduce virus transmission has stimulated scientific and political leaders to claim that ending the HIV epidemic is now a realistic goal. But large funding gaps threaten the gains already made and limit the potential to capitalize on the latest scientific progress. Through the discussion of our treatment programs, field experiences, and operational strategies, MSF will highlight the models of care, tools, and policies necessary to get the best treatment to the most people.
Booth location: Exhibit Hall C, Booth 18
MSF at the IAC blog: